Divya Grover

Baxter forecasts upbeat 2018; expects more buybacks, deals

Feb 01 2018

Baxter International Inc on Thursday forecast 2018 earnings largely ahead of analysts' estimates and said it would continue to be active on the acquisition front and repurchase more shares through the year.

North Korea threats spur U.S. search for new radiation therapies

Jan 31 2018

The escalating threat of a potential nuclear war between North Korea and the United States has led the Department of Defense to join hands with a clutch of companies in developing more effective medical treatments for acute radiation syndrome.

Pfizer's new tax rate higher than investors hoped, shares fall

Jan 30 2018

Pfizer Inc said on Tuesday it expected to pay tax at an adjusted rate of about 17 percent this year, higher than some investors had expected, sending its shares down more than 3 percent. | Video

Abbott to take a pause after deal spree

Jan 24 2018

Abbott Laboratories said on Wednesday it was not looking at acquisitions this year as the healthcare company looks to ease its debt burden after a spree of deals last year.

J&J takes $13.6 billion charge related to new U.S. tax law

Jan 23 2018

Healthcare conglomerate Johnson & Johnson on Tuesday took a $13.6-billion charge related to the new U.S. tax law and plans to bring back billions of dollars from overseas immediately.

UnitedHealth raises 2018 profit outlook, to take benefit from tax law

Jan 16 2018

UnitedHealth Group Inc on Tuesday raised its outlook for 2018 earnings per share by more than 16 percent due to the U.S. corporate tax cut and said it will speed up technology investments that aim to cut customer costs.

CVS Health expects tax overhaul to boost cash flow, shares rise

Jan 04 2018

CVS Health Corp said on Thursday it expects the recent tax reform to boost its cash flow by about $1.2 billion, sending its shares up nearly 5 percent in afternoon trading.

FDA rejects Agile's contraceptive patch, shares plunge

Dec 22 2017

Agile Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its contraceptive patch for the second time, sending the drug developer's shares down about 50 percent.

Gene therapy developer Orchard Therapeutics raises $110 million

Dec 20 2017

Orchard Therapeutics said on Wednesday it raised $110 million in the second round of funding as the drug developer looks to launch its gene therapy to treat a rare inherited disorder and beef up manufacturing facilities.

Tenet puts Conifer unit up for sale, plans more cost cuts

Dec 19 2017

Tenet Healthcare Corp on Tuesday said it is putting its Conifer unit up for sale and plans to cut $100 million more in costs, as its new chief executive works to slash its heavy debt load.

World News